ViroPharma Incorporated (Nasdaq: VPHM) announced that it has received a Complete Response letter from the FDA related to its supplemental ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE